Clinical Trials

Rectal neuroendocrine tumor

Displaying 3 studies

Study Using Chromogranin A As Surveillance Biomarker In Patients With CARcinoids Rochester, MN

The purpose of this study is to monitor and validate the performance and stability of the BRAHMS Chromogranin A (CgA) II KRYPTOR Assay in patients with Gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
A Registry of Biospecimens at Mayo Clinic to Support Translational Research into the Biology, Etiology and Prognosis of Neuroendocrine Tumors Jacksonville, FL

The purpose of this registry at Mayo Clinic Jacksonville, is to keep a database and biospecimens of all patients treated surgically and non-surgically for a gastro-enteropancreatic mass or a suspected metastatic lesion from a gastro-entero-pancreatic primary. This registry will keep demographic, clinical and pathologic data on each patient as well as follow-up information on outcome endpoints such as death and recurrence of disease, blood cell samples, and tissue samples from surgically removed tumors.
A Study To Evaluate Exercise For Cancer Patients At Risk Of Falling Rochester, MN

The purpose of this study is to develop a data-driven approach that enables healthcare providers to “prescribe” exercise in the appropriate dose in a manner analogous to prescribing a drug.